Pharmacological investigations of benzothiazoline derivatives.
D000588:Amines / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000633:toxicity; D001593:Benzyl Compounds / Q000494:pharmacology; D001831:Body Temperature / Q000187:drug effects; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005557:Formaldehyde; D006168:Guinea Pigs; D007928:Lethal Dose 50; D008297:Male; D008744:Methylamines / Q000494:pharmacology; D010047:Ovalbumin; D010113:Oxyphenbutazone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D013276:Stomach Ulcer / Q000139:chemically induced; D013329:Structure-Activity Relationship; D013844:Thiazoles / Q000494:pharmacology* / Q000633:toxicity
D000588:Amines; D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001593:Benzyl Compounds; D008744:Methylamines; D010879:Piperazines; D011720:Pyrazoles; D013844:Thiazoles; D005557:Formaldehyde; D002351:Carrageenan; D010047:Ovalbumin; D010653:Phenylbutazone; D010113:Oxyphenbutazone